Display Settings:

Format

Send to:

Choose Destination

    Clin Cancer Res. 2009 Sep 15;15(18):5606-8. Epub 2009 Sep 8.

    Prevention of progression in monoclonal gammopathy of undetermined significance.

    Rajkumar SV.

    Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA. rajkumar.vincent@mayo.edu

    Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma. Because myeloma is an incurable malignancy, strategies to delay or prevent progression in high-risk patients are of considerable importance.

    PMID: 19737944 [PubMed - in process]

    PMCID: 2759099

    LinkOut - more resources

    Full Text Sources:

    Other Literature Sources:

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read